FilingPulse

CARM insider filings

Carisma Therapeutics Inc. — 33 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-10-08. Screen CARM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CARM between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.

Recent insider filings — Carisma Therapeutics Inc.

FiledFormInsiderReported transactionsSource
2025-10-084Klichinsky Michael — Chief Scientific OfficerOption exercise (M): 56,982 @ $0.11 · Sale (S): 56,982 @ $0.25 · Option exercise (M): 56,982 (derivative) @ $0EDGAR
2025-10-034Klichinsky Michael — Chief Scientific OfficerSale (S): 165,000 @ $0.26 · Sale (S): 200,000 @ $0.25 · Sale (S): 119,347 @ $0.26EDGAR
2025-01-304Klichinsky Michael — Chief Scientific OfficerGrant/award (A): 221,000 (derivative) @ $0EDGAR
2025-01-304Kelly Steven — President and CEO, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2024-11-014Cheng Sohanya Roshan — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2024-07-014Thorell Marella — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2024-07-014Scadden David — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2024-06-274Morrison Briggs — DirectorGrant/award (A): 19,350 (derivative) @ $0EDGAR
2024-06-274Hohneker John — DirectorGrant/award (A): 19,350 (derivative) @ $0EDGAR
2024-06-274Torok Michael — DirectorGrant/award (A): 19,350 (derivative) @ $0EDGAR
2024-06-274ZWEIFACH SANFORD S — DirectorGrant/award (A): 19,350 (derivative) @ $0EDGAR
2024-06-184Klichinsky Michael — Chief Scientific OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2024-06-184Morris Richard Steven — Chief Financial OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2024-06-184Kelly Steven — President and CEO, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2024-04-014Hohneker John — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2024-02-024Klichinsky Michael — Chief Scientific OfficerGrant/award (A): 170,500 (derivative) @ $0EDGAR
2024-02-024Morris Richard Steven — Chief Financial OfficerGrant/award (A): 170,500 (derivative) @ $0EDGAR
2024-02-024Kelly Steven — President and CEO, DirectorGrant/award (A): 438,000 (derivative) @ $0EDGAR
2023-06-084Torok Michael — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2023-06-084Klichinsky Michael — Chief Scientific OfficerGrant/award (A): 238,000 (derivative) @ $0EDGAR
2023-06-084Ugwumba Chidozie — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2023-06-084Morrison Briggs — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2023-06-084Morris Richard Steven — Chief Financial OfficerGrant/award (A): 238,000 (derivative) @ $0EDGAR
2023-06-084Kelly Steven — President and CEO, DirectorGrant/award (A): 600,000 (derivative) @ $0EDGAR
2023-06-084ZWEIFACH SANFORD S — DirectorGrant/award (A): 38,700 (derivative) @ $0EDGAR
2023-03-094Ugwumba Chidozie — DirectorGrant/award (A): 2,215,877EDGAR
2023-03-094Hodits Regina — DirectorGrant/award (A): 2,297,546EDGAR
2023-03-094Klichinsky Michael — Chief Scientific OfficerGrant/award (A): 484,347 · Grant/award (A): 56,982 (derivative) · Grant/award (A): 75,976 (derivative) · Grant/award (A): 112,064 (derivative)EDGAR
2023-03-094Torok Michael — DirectorGrant/award (A): 51,250 · Grant/award (A): 319,991 · Grant/award (A): 50,000EDGAR
2023-03-094Morrison Briggs — DirectorGrant/award (A): 12,175 · Grant/award (A): 63,310 (derivative) · Grant/award (A): 34,189 (derivative)EDGAR
2023-03-094Morris Richard Steven — Chief Financial OfficerGrant/award (A): 331,114 (derivative)EDGAR
2023-03-094Kelly Steven — President and CEO, DirectorGrant/award (A): 625,797 (derivative) · Grant/award (A): 415,968 (derivative)EDGAR
2023-03-094ZWEIFACH SANFORD S — DirectorGrant/award (A): 413 · Grant/award (A): 184,621 (derivative)EDGAR

Recent 8-K events — Carisma Therapeutics Inc.

FiledFormItems reportedSource
2025-12-058-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers		EDGAR
2025-10-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
2025-10-098-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-09-188-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
8.01 — Other Events		EDGAR
2025-08-298-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-08-088-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-07-158-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-06-238-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-128-K8.01 — Other EventsEDGAR
2025-04-168-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CARM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →